Ireland· IE-PA-EU/1/18/1349/001
Dectova 10 mg/mL solution for infusion
A zanamivir product containing zanamivir, registered in Ireland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Zanamivir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AH01 (zanamivir), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Zanamivir · ATC J05AH01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Zanamivir
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Ireland (IE)
- ATC code
- J05AH01
- ATC class
- Zanamivir
- Defined daily dose
- 20 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1349/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
13 interactions on record for zanamivir.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zanamivir · interactions on record
13 records
- 5 moderate
- 8 info
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zanamivir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDectova 10 mg/mlGlaxoSmithKline Pharmaceuticals
- CzechiaDECTOVAGlaxoSmithKline Trading Services Limited, Dublin
- SpainDECTOVA 10 MG/ML SOLUCION PARA PERFUSIONGlaxosmithkline Trading Services Limited
- FinlandDectovaGlaxoSmithKline Trading Services Limited
- IcelandDectovaGlaxoSmithKline Trading Services Limited
- NorwayDectovaGlaxoSmithKline Trading Services Limited
- PolandDectovaGlaxoSmithKline Trading Services Limited
- SwedenDectova 10 mg/ml Infusionsvätska, lösningGlaxoSmithKline Trading Services Ltd
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Relenza Rotadisks
- Belgium · Relenza
- Bulgaria · Реленца
- Germany · Relenza
- Denmark · Relenza
- Spain · Relenza
- Finland · Relenza
- France · Relenza
- United Kingdom (Northern Ireland) · Relenza
- Croatia · Relenza
- Iceland · Dectova, Relenza
- Italy · Relenza
- Liechtenstein · Dectova
- Luxembourg · Relenza
- Netherlands · Relenza
- Norway · Dectova, Relenza
- Poland · Relenza
- Portugal · Relenza
- Sweden · Relenza
- Slovenia · Relenza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/79ac2a04-d268-4e2c-abe0-3aaff3c690e6 GET /v1/drugs/79ac2a04-d268-4e2c-abe0-3aaff3c690e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J05AH",
"J05AH01"
],
"strength": null,
"pa_number": "EU/1/18/1349/001",
"substances": [
"Zanamivir"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/04/2019",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about zanamivir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.